Skip to main content
. 2019 Dec 30;9(1):11. doi: 10.3390/antibiotics9010011

Table 1.

Summary of clinically tested commercial LDA for nonsurgical periodontal therapy based on longest follow-up period.

Active Agent Brand Manufacturer Dosage Delivery Vehicle Application and Duration (per Manufacturer/Study Design) Longest Follow-Up Study Authors Study Design Sample Size
Chlorhexidine Chlo-Site® Ghimas Company, Italy 1.5% CHX Gel 1 application
15 days treatment
6 months Paolantonio et al. 2009 [41] Split-mouth 98
Kranti et al. 2010 [42] Split-mouth 10
Jain et al. 2013 [43] Split-mouth 30
Matesanz et al. 2013 [44] Parallel 22
Periochip® Perio Products Ltd., Jerusalem, Israel 2.5 mg CHX gluconate Chip 1 application
7 days treatment
9 months Jeffcoat et al. 1998 [45] Parallel * 419
Grisi et al. 2002 [46] Parallel * 20
Carvalho et al. 2007 [47] Split-mouth * 28
PerioCol®-CG Eucare Pharmaceuticals Ltd., Chennai, India 2.5 mg CHX gluconate Chip 1 application
7 days treatment
12 months Reddy et al. 2016 [48] Parallel 48
EC40® Biodent BV, Nijmegen, The Netherlands 35% CHX diacetate Varnish 1 application
7 days treatment
9 months Cosyn et al. 2006 [49] Parallel 26
Doxycycline Atridox® Atrix Laboratories, Fort Collins, CO, USA 10% DOXY hyclate Gel 1 application
7 days treatment
36 months Bogren et al. 2008 [50] Parallel * 132
Metronidazole Elyzol® Dumex, Copenhagen, Denmark 25% MET benzoate Gel 2 applications
7 days treatment
12 months Buduneli et al. 2001 [51] Split-mouth 18
Minocycline Arestin® OraPharma, Inc., Warminster, PA, USA 1 mg MINO hydrochloride Micro-spheres 1 application
14 days treatment
24 months Cortelli et al. 2008 [52] Parallel * 30
Killeen et al. 2018 [53] Parallel * 55
Dentomycin® Lederle Dental Division, Gosport, Hampshire, UK 2% MINO hydrochloride Ointment 3–4 applications
14 days treatment
18 months Timmerman et al. 1996 [54] Parallel * 20
Periocline® Sunstar Corp., Tokyo, Japan
Tetracycline Periodontal Plus ABTM Advanced Biotech Products, Chennai, India 2 mg TET hydrochloride 1 application
7 days treatment
12 months Reddy et al. 2016 [48] Parallel 48
Enamel matrix derivative Emdogain® Institute Straumann AG, Basel, Switzerland 30 mg/mL porcine enamel matrix derivative Gel 1 application 12 months Mombelli et al. 2005 [55] Split-mouth 16
Hyaluronic acid Aftamed® BioPlax Limited, London, UK 240 mg/100 g sodium hyaluronate Gel 1 application 6 weeks Omer at el. 2018 [56] Split-mouth 33
Aminogam® Errekappa Euroterapici, Spa, Italy Sodium hyaluronate, amino acids 1 application 3 months Bevilacqua et al. 2012 [57] Split-mouth * 11
Gengigel® Ricerfarma, Italy 0.2% and 0.8% Sodium hyaluronate 1 application 6 months Eick et al. 2013 [58] Parallel * 42
Healon GV® Pharmacia and Upjohn, Uppsala, Sweden. 14 mg/mL sodium hyaluronate 3 applications
27 days treatment
12 months Engstrüm et al. 2001 [59] Split-mouth * 9
Photosensitiser EmunDo® A.R.C. laser GmbH, Germany Indocyanine green (iodide-free) Dye Solution 2–4 applications
14–27 days treatment
3 months Birang et al. 2015 [60] Split-mouth 20
Monzavi et al. 2016 [61] Split-mouth * 25
HELBO® Bredent Medical, Germany Phenothiazine chloride 1 application 12 months Lulic et al. 2009 [62] Parallel 10
Alwaeli et al. 2015 [63] Split-mouth * 21
Petelin et al. 2015 [64] Parallel * 27
Tabenski et al. 2017 [65] Parallel 48
PeriowaveTM Periowave Dental Technologies Inc, Canada Methylene blue 1–3 applications 6 months Berakdar et al. 2012 [66] Split-mouth 22
Müller Campanile et al. 2015 [67] Split-mouth * 28
Fotosan® CMS Dental, Copenhagen, Denmark Toluidine blue/tolonium chloride 1–3 applications 6 months Goh et al. 2017 [68] Split-mouth 27

CHX: Chlorhexidine; MINO: Minocycline; DOXY: Doxycycline; MET: Metronidazole; TET: Tetracycline. * Repeated application.